Ann R. Falsey

Active 1992–2025

Also published as
Ann R Falsey
141
Papers
24,947
Citations
80
h-index
130
i10-index

Citations

Citations per year for Ann R. Falsey1992: 1 citations1994: 1 citations1995: 3 citations1996: 9 citations1997: 19 citations1998: 16 citations1999: 29 citations2000: 38 citations2001: 35 citations2002: 42 citations2003: 82 citations2004: 109 citations2005: 109 citations2006: 87 citations2007: 68 citations2008: 100 citations2009: 78 citations2010: 83 citations2011: 114 citations2012: 97 citations2013: 114 citations2014: 98 citations2015: 144 citations2016: 133 citations2017: 167 citations2018: 154 citations2019: 527 citations2020: 844 citations2021: 1,792 citations2022: 1,181 citations2023: 861 citations2024: 1,462 citations2025: 787 citations2026: 6 citations1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,881 citing papers, 26.4% of this breakdownUnited Kingdom: 795 citing papers, 7.3% of this breakdownChina: 724 citing papers, 6.6% of this breakdownGermany: 500 citing papers, 4.6% of this breakdownItaly: 407 citing papers, 3.7% of this breakdownCanada: 401 citing papers, 3.7% of this breakdownFrance: 372 citing papers, 3.4% of this breakdownNetherlands: 336 citing papers, 3.1% of this breakdownSpain: 315 citing papers, 2.9% of this breakdownAustralia: 299 citing papers, 2.7% of this breakdownBelgium: 268 citing papers, 2.4% of this breakdownSwitzerland: 231 citing papers, 2.1% of this breakdown
0%26.4%Other 31.1%

Fields

  • Medicine80.9%
  • Biochemistry, Genetics and Molecular Biology8.8%
  • Immunology and Microbiology6%
  • Social Sciences0.9%
  • Mathematics0.6%
  • Health Professions0.6%
  • Other2.2%

Topics

  • Respiratory viral infections research12.5%
  • SARS-CoV-2 and COVID-19 Research11.6%
  • COVID-19 Clinical Research Studies6.7%
  • Pneumonia and Respiratory Infections4.1%
  • Influenza Virus Research Studies3.6%
  • Viral gastroenteritis research and epidemiology3.6%
  • Other57.9%

Coauthors

All papers

Open in search
  1. Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Beate Schmöele-Thoma - New England Journal of Medicine 2023 cited by 636

  2. Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults

    Authors: , , , , - New England Journal of Medicine 2005 cited by 2,212

  3. Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacqueline M. Miller, Rituparna Das, Grace Chen - New England Journal of Medicine 2023 cited by 453

  4. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 2,730

  5. Global Disease Burden Estimates of Respiratory Syncytial Virus–Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Terho Heikkinen, Adam Meijer, Thea Kølsen Fischer, Maarten van den Berge, Carlo Giaquinto, Rafael Mikolajczyk, Judy Hackett, Bing Cai, Charles Knirsch, Amanda Leach, Sonia K Stoszek, Scott Gallichan, Alexia Kieffer, Clarisse Demont, Angéline Denouel, Arnaud Chéret, Sandra Gavart, Jeroen Aerssens, Robert Fuentes, Brian Rosen, Harish Nair, Harry Campbell, Ting Shi, Shanshan Zhang, You Li, Peter Openshaw, Jadwicha Wedzicha, Ann R. Falsey, Mark Miller, Philippe Beutels, Louis Bont, Andrew J. Pollard, Eva Molero, Federico Martinón‐Torres, Terho Heikkinen, Adam Meijer, Thea Kølsen Fischer, Maarten van den Berge, Carlo Giaquinto, Rafael Mikolajczyk, Judy Hackett, Bing Cai, Charles Knirsch, Amanda Leach, Sonia K Stoszek, Scott Gallichan, Alexia Kieffer, Clarisse Demont, Angéline Denouel, Arnaud Chéret, Sandra Gavart, Jeroen Aerssens, Robert Fuentes, Brian Rosen - The Journal of Infectious Diseases 2019 cited by 526

  6. Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis

    Authors: , , , , , - Open Forum Infectious Diseases 2022 cited by 214

  7. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 1,594

  8. Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tina Tong, Margaret Brewinski Isaacs, David Benkeser, Holly E. Janes, Martha C. Nason, Justin A. Green, Elizabeth J. Kelly, Jill Maaske, Nancy Mueller, Kathryn Shoemaker, Therese Takas, Richard P. Marshall, Menelas N. Pangalos, Tonya Villafana, Antonio Gonzalez-Lopez - New England Journal of Medicine 2021 cited by 683

  9. Long-Lived Plasma Cells Are Contained within the CD19−CD38hiCD138+ Subset in Human Bone Marrow

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2015 cited by 542

  10. Incidence of Respiratory Syncytial Virus Infection Among Hospitalized Adults, 2017-2020.

    Authors: , , , , , , , , , - Clinical Infectious Diseases 2021 cited by 245

  11. Diagnosis of Respiratory Syncytial Virus in Adults Substantially Increases When Adding Sputum, Saliva, and Serology Testing to Nasopharyngeal Swab RT–PCR

    Authors: , , , , , , , , , , , , , , , , , , - Infectious Diseases and Therapy 2023 cited by 103

  12. Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 146

  13. Human Metapneumovirus Infections in Adults

    Authors: , , - Archives of Internal Medicine 2008 cited by 246

  14. Respiratory Syncytial Virus Infection in Older Adults: An Under-Recognized Problem

    Authors: , - Drugs & Aging 2015 cited by 200

  15. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Louis Bont - The Lancet Infectious Diseases 2018 cited by 474

  16. Disease Burden Estimates of Respiratory Syncytial Virus related Acute Respiratory Infections in Adults With Comorbidity: A Systematic Review and Meta-Analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Peeters, Brian Rosen, Robert Fuentes, Ann R. Falsey, Rafael Mikolajczyk, Larry Anderson - The Journal of Infectious Diseases 2021 cited by 117

  17. Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness

    Authors: , , , , , , , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2014 cited by 298

  18. Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2020 cited by 159

  19. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bin Cao, Yahya Shehabi, Jens‐Ulrik Stæhr Jensen, Caspar Corti, Jos A. H. van Oers, Albertus Beishuizen, Armand R. J. Girbes, Evelien de Jong, Matthias Briel, Beat Müeller - The Lancet Infectious Diseases 2017 cited by 473

  20. A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine

    Authors: , , , , , , , , , , , , - The Journal of Infectious Diseases 2021 cited by 102

  21. Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine

    Authors: , , , , , , , , , , , , - The Journal of Infectious Diseases 2021 cited by 80

  22. Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eva Molero, Federico Martinón‐Torres, Terho Heikkinen, Adam Meijer, Thea Kølsen Fischer, Maarten van den Berge, Carlo Giaquinto, Rafael Mikolajczyk, Judy Hackett, Eskinder Tafesse, Antonio Gonzalez Lopez, Ilse Dieussaert, Nadia Dermateau, Sonia Stoszek, Scott Gallichan, Alexia Kieffer, Clarisse Demont, Arnaud Chéret, Sandra Gavart, Jeroen Aerssens, Veronique Wyffels, Matthias Cleenewerck, Robert Fuentes, Brian Rosen, Harish Nair, Harry Campbell, Ting Shi, Shanshan Zhang, You Li, Peter Openshaw, Jadwicha A Wedzicha, Ann R. Falsey, Mark Miller, Philippe Beutels, Marina Antillon, Joke Bilcke, Xiao Li, Louis Bont, Andrew Pollard, Eva Molero, Federico Martinón‐Torres, Terho Heikkinen, Adam Meijer, Thea Kølsen Fischer, Maarten van den Berge, Carlo Giaquinto, Rafael Mikolajczyk, Judy Hackett, Eskinder Tafesse, Antonio Gonzalez Lopez, Ilse Dieussaert, Nadia Dermateau, Sonia Stoszek, Scott Gallichan, Alexia Kieffer, Clarisse Demont, Arnaud Chéret, Sandra Gavart, Jeroen Aerssens, Veronique Wyffels, Matthias Cleenewerck, Robert Fuentes, Brian Rosen - The Journal of Infectious Diseases 2019 cited by 164

  23. Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults

    Authors: , , , , , , , , - Influenza and Other Respiratory Viruses 2022 cited by 75

  24. Parainfluenza Virus Infection

    Authors: , - Seminars in Respiratory and Critical Care Medicine 2016 cited by 228